Q97927186

Summary

Q97927186 is a committee group motion^[1].

Key Facts

• Q97927186 authored Gunilla Wahlén^[2].
• Q97927186 authored Ingrid Burman^[3].
• Q97927186 authored Elina Linna^[4].
• Q97927186's instance of is recorded as committee group motion^[5].
• Q97927186's part of the series is recorded as motions of the 2003-2004 legislative session of the Riksdag^[6].
• Q97927186's language of work or name is recorded as Swedish^[7].
• Q97927186's publication date is recorded as +2003-12-04T00:00:00Z^[8].
• Q97927186's main subject is recorded as medication^[9].
• Q97927186's work available at URL is recorded as http://data.riksdagen.se/dokument/GR02So9^[10].
• Q97927186's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GR02So9^[11].
• Q97927186's applies to jurisdiction is recorded as Sweden^[12].
• Q97927186's legal citation of this text is recorded as Mot. 2003/04:So9^[13].
• Q97927186's title is recorded as med anledning av prop. 2003/04:32 Genomförande av EG-direktivet om kliniska prövningar av humanläkemedel^[14].
• Q97927186's has immediate cause is recorded as Q98138704^[15].
• Q97927186's cites work is recorded as Q98138704^[16].
• Q97927186's maintained by WikiProject is recorded as Project Riksdagen's documents^[17].
• Q97927186's copyright status is recorded as public domain^[18].
• Q97927186's legislative committee is recorded as Committee on Health and Welfare^[19].
• Q97927186's Swedish Riksdag document ID is recorded as GR02So9^[20].

Body

Works and Contributions

Authored works include Gunilla Wahlén^[2], a politician^[21], b. 1951^[22], of Sweden^[23]; Ingrid Burman^[3], a politician^[24], b. 1952^[25], of Sweden^[26]; and Elina Linna^[4], a politician^[27], 1947–2023^[28], of Sweden^[29].